| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |